The study of APP and its metabolites is an important part of the investigation into the mechanism of AD, and there are many potential drug targets in the pathogenesis, for which it is scientifically important and clinically promising to design advanced drugs for the treatment of AD. The gene discussed is APP; the disease is Alzheimer disease.